SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

SNDX is currently covered by 11 analysts with an average price target of $40. This is a potential upside of $30.87 (338.12%) from yesterday's end of day stock price of $9.13.

Our record on SNDX covers 27 analysts since 2008; 10 cover it today. Of the 183 price targets those analysts set on SNDX, 47 were reached (26%). The highest performance score on SNDX belongs to Edward White of H.C. Wainwright: 5.05, with 7 of 30 targets met in 495 days on average. The latest calls: David Dai of UBS cut the target to $33 from $37 with a Buy rating on 21 Aug 2026; Anupam Rama of JPMorgan cut the target to $40 from $45 with a Buy rating on 11 Aug 2026; Andres Maldonado of H.C. Wainwright cut the target to $38 from $40 with a Buy rating on 5 Aug 2026. Figures as of 18 Nov 2026.

Syndax Pharmaceuticals's activity chart (see below) currently has 240 price targets and 185 ratings on display. The stock rating distribution of SNDX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 22.54% of the time, taking 179 days on average.

Highest price target for SNDX is $57, Lowest price target is $29, average price target is $40.

Most recent stock forecast was given by DAVID DAI from UBS. First documented stock forecast 27-Mar-2016.

Currently out of the existing stock ratings of SNDX, 24 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Oct-2024

$31

$21.87 (239.54%)

$33

1 days ago
(19-Nov-2026)

Buy Since 15-Oct-2025

$36

$26.87 (294.30%)

$38

18 days ago
(02-Nov-2026)

0/8 (0%)

$21.71 (151.92%)

Buy Since 02-Jan-2023

$40

$30.87 (338.12%)

$45

3 months 10 days ago
(10-Aug-2026)

0/16 (0%)

$19.71 (97.14%)

Buy Since 26-Feb-2026

$46

$36.87 (403.83%)

$46

5 months 6 days ago
(14-Jun-2026)

0/4 (0%)

$27.52 (148.92%)

Buy Since 29-Jan-2023

$31

$21.87 (239.54%)

$34

5 months 9 days ago
(11-Jun-2026)

0/9 (0%)

$12.75 (69.86%)

Show more analysts

Please expand the browser size to see the chart

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 179 days for the stock forecasts to be reached, with an average price target met ratio of 22.54%.

Which analyst most recently updated their price target on SNDX (Syndax Pharmaceuticals)?

David Dai

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

David Dai works at UBS and has 7 price targets and 5 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Yigal Nochomovitz with the highest potential upside of $47.87

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

George Farmer with the lowest potential downside of -$4.31
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?